Achilles Therapeutics announced the appointment of Arjan Roozen as VP, Site Head and General Manager, with responsibility for scaling up Achilles’ manufacturing operations to supply cell therapy products for late-stage clinical studies and commercial supply. Arjan brings over 25 years of experience in the field of advanced therapies and Good Manufacturing Practices (GMP) operations, from early phase to commercial manufacture. Arjan joins Achilles from Zelluna Immunotherapy where he was Chief Technology Officer responsible for GMP manufacturing for all product programmes and managing external contract laboratories. He also gained extensive cell therapy experience from his time at Cellectis where he was VP GMP Solutions/Manufacturing and involved in the company’s allogeneic CAR T programme.